The recognition of the non-specific action of chemical or other agents used therapeutically owes much to the theories and experimental work of Selye (1950a) . He traced out a pattern of reaction which longitudinally was termed the general adaptation syndrome (Selye, 1946) and in crosssection appears to be essentially triphasic (Selye, 1950b) . Selye suggested that the first part of this be known as the alarm reaction, the implication being that adaptation had not as yet been acquired; this was followed by the stage of resistance during which adaptation was optimal, and if the stimulus or stress should persist, then the stage of exhaustion supervened. An agent producing an alarm reaction was termed a stressor (Selye, 1950c) and might exert both specific and non-specific effects (Selye, 1951) . Insulin, for instance, acts both nonspecifically (Paschkis, Cantarow, Walkling, and Boyle, 1950) and specifically by increasing the peripheral assimilation of sugar and the deposition of glycogen in the liver (Soskin, 1941 ; Bouckaert and de Duve, 1947) .
The value of both insulin and electroplexy (E.C.T.) in the treatment of the schizophrenias has been thought of by some to owe much to their non-specific effects. Thus Roth and Rosie (1953) liken the action of E.C.T. to that of other nonspecific therapies such as A.C.T.H. and cortisone, emphasizing that it is unlikely to act directly upon the causes of psychiatric disorders but rather upon the regulatory and defensive mechanisms of the organism. Sackler, Sackler, Sackler, La Burt, van Ophuijsen, and Co Tui (1951) , while admitting a number of physiological denominators common to E.C.T., insulin coma therapy, histamine and combined sex hormone therapies, nevertheless considered that to explain away all their effects as being non-specific might amount to the dismissal of other important factors in their action.
It is the purpose of this paper to suggest that various biochemical and tissue deviations that have been hitherto assigned either diagnostic or prog-* Abstracted partly from a thesis accepted for the degree of M. D. Cantab., 1953. nostic status, and which occur concurrently with, and in apparent direct relation to, treatment could as reasonably be integrated with patterns of nonspecific homeostasis.
Such criteria include that of Meduna (1950) , who postulated a clinical distinction between endogenous schizophrenia and a syndrome he designated " oneirophrenia", one of the differences being that the latter patients exhibited resistance to insulin in the intravenous insulin tolerance test. This resistance was a reversible phenomenon, the reaction reverting to a normal hypoglycaemic response pari passu as the patient improved with the administration of E.C.T., the reversion being an additional hall-mark of the benignity of the condition in contrast to the more sinister outlook for the true schizophrenias.
Other work on prognostic criteria includes that ofRud (1947a) who demonstrated that the administration of " cardiazol ", E.C.T., and deep insulin therapy was succeeded by an immediate eosinopenia, but that in addition three weeks after beginning insulin there was a distinct increase in the eosinophil cells. He deemed that this rising eosinophil count was of therapeutic importance and that it indicated a patient who might benefit from one of the shock treatments. Sackler and others (1951) also observed an apparent correlation between an improvement in the patient's clinical status and the degree of eosinophilia. Altschule, Siegel, Restaino, and Parkhurst (1952) remarked upon this eosinophilia in patients who showed improvements after shock treatments, and affirmed that in their study patients with decreases in the cell count persisting after the end of treatment were not improved. Similarly, Alexander and Neander (1953) comment that in their series those patients who showed no rise in the resting eosinophil count during therapy evinced no alteration in their eventual mental state. Shands and Menzer (1953) (Rud, 1947b) . Capillary blood was then withdrawn for estimation of the fasting blood sugar, after which the insulin was injected. At 20, 30, 45, 60, 90 , and 120 minutes afterwards further samples of blood were taken. The blood sugars were estimated by the method devised by Herbert and Bourne (1930) , which is a determination of the true blood glucose. As it has been demonstrated that hypoglycaemia is accompanied by an eosinopenia (Perlmutter and Mufson, 1951) and that this is most prominent four hours after stress, the eosinophils in addition to being counted at 9 a.m. were also checked at 1 p.m. The difference between the 9 a.m. and 1 p.m. counts for the group was calculated and termed the " mean eosinopenia."
As the results of insulin tolerance tests repeated at short intervals were being compared, it was essential to show that repeated tests under normal circumstances manifested no significant statistical dissimilarity. This was done and it was seen that the results of insulin tolerance tests repeated at short intervals were strictly comparable (Marley, 1953 (Fraser and others, 1941) . In addition, the mean fall of blood sugar 30 minutes after the beginning of the test was calculated for the group as a whole and compared before, during, and after cessation of treatment.
Capillary-blood was used in eosinophil counting, and both the technique and the phloxine-urea diluent proposed by Manners (1951) were adopted. The eosinophil counts performed during treatment, but not associated with insulin tolerance tests, were also done at approximately 9 a.m., and those reported here derive from the mean of two counts estimated twice weekly.
For each count, two white-cell pipettes were filled to the 1 mark with blood and to the 11 mark with the phloxine-urea diluent. The pipettes were immediately shaken for two to three minutes and then the four counting chambers (two double-sided Fuchs-Rosenthal chambers) were filled by capillation. The counting chambers were set aside in a moist environment prepared by placing a few sheets of filter paper soaked with water in the bottom of a large Petri dish. Within 15 minutes nearly all the leucocytes other than the eosinophils were lysed. The count was then performed under the 16 mm. microscope objective with a x 10 eyepiece. All the ruled area of the chamber was counted, and as the total volume of the four chambers was 12 8 c.mm. and the dilution 1 in 10, the number of eosinophils per c.mm. was ascertained by dividing the total number counted by 1-28.
Plasma chloride values were estimated by first precipitating silver chloride with the addition of a known amount of silver nitrate and then destroying the proteins by heating with nitric acid. The remaining silver nitrate was titrated with thiocyanate and the amount precipitated calculated, and hence the amount of chloride determined (May and Marrack, 1951) .
No patient was accepted for testing if he was markedly underweight, as it has been demonstrated that changes attributable to the general adaptation syndrome are constantly present in association with severe malnutrition (Selye, 1950d) . For the same reason patients treated in the previous two months with either E.C.T. or deep or modified insulin were rejected (Gellhorn and Safford, 1948; Henneman, Altschule, and Siegel, 1951) .
The results of investigations performed on 22 psychotic patients treated with deep insulin (Nos. 1 to 22), five psychotics treated with E.C.T. (Nos. 23 to 27), and seven patients suffering from neurotic illnesses treated with modified insulin (Nos. 28 to 34) were analysed and compared statistically.
All the values included below derive from tests on the entire groups of patients except for the eosinophilias associated with deep insulin treatment which were calculated from repeated counts on 16 of the 22 psychotics, and the plasma chloride readings which were obtained from repeated estimations on seven of the 22 psychotics of that same group.
The patients were all males, those suffering from psychoses being diagnosed as having schizophrenia. In no instance was an alternative diagnosis of oneirophrenia tenable.
Results
The mean values and their standard deviations derived from the results of tests are presented in Tables I, II , and III. The mean fall of blood sugar, the mean eosinopenia, the mean fasting blood sugar levels, and the mean plasma chloride values were From these Tables it can be seen that the mean fall of blood sugar is increased during and immediately after the cessation of therapy, most particularly between the fifth and twelfth days of treatment. Similarly, the mean of the fasting blood sugars is increased during and immediately after therapy, most noticeably during the later phases of treatment. The mean eosinopenia declines rapidly during and immediately after therapy. The mean value for the plasma chlorides increased during treatment with deep insulin, most markedly between the fifth and twelfth days of therapy. The mean level of eosinophils increased during treatment, the greatest increase taking place during the earlier stages of the course of modified insulin but during the later phases of treatment with deep insulin or E.C.T. However, this mean increase had disappeared soon after the termination of therapy.
The significance of the differences between these mean values has been assessed statistically and presented in Tables 1V, V, and VI. The means compared were those obtained before treatment and those found between the fifth and twelfth days of therapy (Series 1 and 2), the means before treatment and those occurring between the thirteenth day and the cessation of therapy (Series 1 and 3), and those obtained before and after treatment (Series 1 and 4).
From these Tables it can be seen that the hypoglycaemic effect of small doses of insulin is significantly increased during the early phases of deep Table VII. It can be inferred from the latter that increase of sensitivity during or immediately after treatment, following the previous demonstration of resistance to small doses of insulin, may still not be associated with improvement (Case 13), and that no increase Similarly, a significant mean eosinophilia occurred during and immediately after the cessation of therapy with deep insulin, during but not immediately after the completion of a course of E.C.T., and not at all either during or immediately after treatment with modified insulin. The significance of individual mean eosinophilias was assessed by the strict criterion of Berkson, Magath, and Hurn (1940) which requires that any variation from the mean of a cell count should be at least twice the standard deviation of that mean to be significant. The presence or absence of a significant individual eosinophilia was correlated with the clinical status of the patient immediately after the completion of a course of therapy, and the findings are tabulated in Table VIII . Thus, of those patients treated with deep insulin, and of those manifesting individual significant eosinophilias, five were greatly improved, four slightly improved, and three unimproved, whereas, of those patients exhibiting no significant eosinophilia, two were slightly improved and two unimproved. The eosinophilia was significant for all patients treated with E.C.T., and of these one was greatly improved, three slightly improved, and one unimproved. Thus, in the groups treated with deep insulin or E.C.T. the patients exhibited either no eosinophilia or a significant moderate eosinophilia with a maximum mean of 250-4 eosinophils per c.mm. for those treated with deep insulin and a maximum mean of 125-2 eosinophils per c.mm. for those treated with E.C.T. No instances were observed of the very high counts of 1,000 eosinophils per c.mm. or more recorded by Shands and Menzer (1953) or Freeman, Jones, and Palmer (1954) .
The relation of the eosinophilias to prognosis in the group receiving modified insulin was not elucidated, as not all these patients were having treatment exclusively for their mental symptomatology. However, there was an increase in the resting level of eosinophils during the early phase of therapy, although this mean increase -was not statistically significant.
Of those patients treated with deep insulin and on whom the plasma chlorides were estimated, all showed an increase of these values except Case 17. In this patient they remained stationary during and immediately after therapy, and the patient remained unimproved as the result of treatment. Of the rest, one was greatly improved, two slightly improved, and three unimproved immediately after the termination of therapy. The mean increase of the plasma chloride values was statistically significant only during the fifth to twelfth days of therapy. Discussion From the results presented above it can be concluded that resistance to small doses of insulin occurs in schizophrenics in whom the diagnosis of oneirophrenia would be untenable. In addition, a decrease in resistance to small doses of insulin with concomitant clinical recovery may occur in schizophrenics during the course of therapy, and who, again, do not warrant a diagnosis of oneirophrenia. Furthermore, a decrease of insulin resistance may be unaccompanied by clinical improvement, whereas an increase of insulin resistance may be associated with recovery. More important still, if the groups as a whole were considered, an increase in the hypoglycaemic effect of small doses of insulin occurred during or after treatment, no matter whether therapy was with insulin or E.C.T., and hence these changes bear no particular relation to diagnosis or prognosis.
In addition, there was resistance to small doses of insulin in one patient suffering from a neurotic disorder before treatment, and in another during and after the completion of a course of modified insulin. Thus, resistance to insulin can occur both in neurotics and schizophrenics and in fact has been reported in other conditions, for instance, in patients suffering from the malignant phase of hypertension (Olsen and Nuetzel, 1950) . This confirms the opinion of Mayer-Gross (1952) who could discover no positive correlation between the incidence of resistance to small doses of insulin and a diagnosis of oneirophrenia, a conclusion similarly endorsed by Lingjaerde (1952) .
An increase of resting eosinophil cells accompanied treatment with insulin or E.C.T. and bore no clear-cut association to clinical improvement. These findings are in accord with those of Shattock and Micklem (1952) , who reported that an increase in the number of eosinophils occurred both in patients who recovered and in those whose clinical progress was disappointing. More recently, Shands and Menzer (1953) and Freeman and others (1954) have arrived at an identical conclusion.
The mean eosinopenia accompanying serial insulin tolerance tests decreased in magnitude during and after the termination of the various therapies, and it is relevant that Altschule, Parkhurst, and Tillotson (1949) reported that in man the response of the eosinophils to electrically induced convulsions decreased with frequently repeated " shocks ", but that the response may return to its former level after a rest period of at least nine days. They further remark that their findings are reminiscent of the work of Hills, Forsham, and Finch (1948) who noted a diminished eosinopenia after daily injections of adrenocorticotropic hormone. Similarly, Sprague, Mason, and Power (1951) observed that a reduced eosinopenic response accompanied continued administration of cortisone.
Other results that mimic closely the findings presented in this paper have been reported by Masson (1941) who found, after exposing animals to various stressors, that the hypoglycaemic effect of insulin was considerably augmented during the stage of resistance of the general adaptation syndrome. He surmised, therefore, that the hypoglycaemic action of this hormone increases during adaptation to non-specific agents. An equivalent phenomenon has been recorded after lumbo-dorsal sympathectomy and interpreted as a manifestation of the general adaptation syndrome (Simeone and Vavoudes, 1948; Simeone, 1949) . A transient eosinophilia was observed by White (1951) during the experimental production of the general adaptation syndrome in sheep, and Laragh and Almy (1948) and Johnson, Conn, lob, and Coller (1950) have suggested that the eosinophilia following upon the stress of traumatic injury may be in some way linked with the adaptation syndrome. Last, Jordan, Pitesky, and Siegel (1950) noted that a diminished eosinopenic response accompanied adaptation to stress induced by adrenalin. Likewise, Jordan, Pitesky, Bond, Johnson, and Last (1950) observed a decreased eosinophil response in association with adaptation to stress. Hence the increased hypoglycaemic effect of small doses of insulin, the diminished eosinopenias, and the elevation of the level of eosinophils, have been observed during adaptation to stress or accompanying the continued administration of adrenocorticotropic hormone.
As for the other results reported in this paper, the increased values for fasting blood sugars recorded during treatment with deep insulin have been noted previously by Looney and Cameron (1937) . In addition, Gellhorn and Safford (1948) found that the fasting blood sugar of rats was markedly augmented after 10 electro-shocks, but that after a further 14 electro-shocks the fasting blood sugar had declined again to normal values. However, insulin and E.C.T. are so-called stressors, and Selye (1950e) has noted that stress is accompanied by an initial hyperglycaemia succeeded later by hypoglycaemia, although eventually during the countershock phase, the blood sugar returns to normal and remains at, or slightly above, this level; that is, throughout the entire stage of resistance of the general adaptation syndrome. But the anterior pituitary and adrenocortical hormones are the major factors in maintaining a fasting blood sugar level (Long, 1952) Thus, the increase in the hypoglycaemic effect of small doses of insulin, of fasting blood sugar levels and eosinophil cells, and the diminished eosinopenias and increased plasma chloride values that accompany the administration of a course of insulin or E.C.T. are seen also in association with the continued injections of adrenocorticotropic hormone or the development of the stage of resistance of the general adaptation syndrome. Hence these changes. are best considered as being non-specific.
Summary
The presence of resistance to small doses of insulin in schizophrenics, or the disappearance of this. resistance during treatment, has no diagnostic or prognostic worth. The same may be said for the increase, or absence of increase, of the values for the resting eosinophil cell counts before, during, or after therapy.
The increased hypoglycaemic effect of small doses of insulin, of fasting blood sugar levels and resting plasma chloride values, of increased eosinophil cell counts, and diminished eosinopenic response associated with the progress of treatment appear to be non-specific and to represent tissue and biochemical adaptation to the repeated administration of insulin or E.C.T.
